Your browser doesn't support javascript.
loading
Neuroprotective role of a monoterpene (thymol) on diazepam induced withdrawal symptoms in rats.
Saleem, Sadia; Naqvi, Fizza; Batool, Asma; Naqvi, Sajjad Haider; Naqvi, Faizan; Batool, Zehra; Tabassum, Saiqa; Haider, Saida.
Afiliação
  • Saleem S; Neurochemistry and Biochemical Neuropharmacology Research Unit, Department of Biochemistry, University of Karachi, Karachi, Pakistan.
  • Naqvi F; Neurochemistry and Biochemical Neuropharmacology Research Unit, Department of Biochemistry, University of Karachi, Karachi, Pakistan.
  • Batool A; Neurochemistry and Biochemical Neuropharmacology Research Unit, Department of Biochemistry, University of Karachi, Karachi, Pakistan.
  • Naqvi SH; Neurochemistry and Biochemical Neuropharmacology Research Unit, Department of Biochemistry, University of Karachi, Karachi, Pakistan.
  • Naqvi F; Neurochemistry and Biochemical Neuropharmacology Research Unit, Department of Biochemistry, University of Karachi, Karachi, Pakistan.
  • Batool Z; Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.
  • Tabassum S; Department of Biosciences, Shaheed Zulfikar Ali Bhutto Institute of Science and Technology, Karachi, Pakistan.
  • Haider S; Neurochemistry and Biochemical Neuropharmacology Research Unit, Department of Biochemistry, University of Karachi, Karachi, Pakistan.
Pak J Pharm Sci ; 34(4(Supplementary)): 1615-1620, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34799339
ABSTRACT
Benzodiazepine administration is known to be related to tolerance and a withdrawal syndrome on sudden cessation. Thymol possesses multiple biological properties especially in the pathogenesis of different brain disorders. However, to the best of our knowledge there is no study that relates the use of thymol to benzodiazepine induced withdrawal symptoms. Therefore the aim of the current study was to investigate the usefulness of thymol in the treatment of benzodiazepine withdrawal syndrome in rats. Animals were divided into four groups, thymol (40mg/kg/ml), diazepam (4 mg/kg), thymol + diazepam and vehicle control group. The treatment was given for 14 days and then suddenly ceased. After 24 h animals were tested in different behavioral paradigms such as physical signs for withdrawal, marble burying test, inverted screen test, elevated plus maze, passive avoidance test and open field activity. The results of the present study revealed that co-administration of thymol significantly reduced the withdrawal symptoms induced by diazepam. Our results further suggest that administration of thymol not only ameliorates rebound anxiety associated with diazepam withdrawal but also improves motor and memory impairment in rats.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Síndrome de Abstinência a Substâncias / Timol / Fármacos Neuroprotetores / Diazepam / Hipnóticos e Sedativos Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Síndrome de Abstinência a Substâncias / Timol / Fármacos Neuroprotetores / Diazepam / Hipnóticos e Sedativos Idioma: En Ano de publicação: 2021 Tipo de documento: Article